|Worldwide Pharmaceuticals to 2021: Drifting Towards Big Data & Analytics - ResearchAndMarkets.com|
|Thursday, 10 January 2019 20:06|
Jan. 11, 2019 17:14 UTC
Worldwide Pharmaceuticals to 2021: Drifting Towards Big Data & Analytics - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)-- The "Pharmaceuticals: Drifting towards Big Data & Analytics - Drivers, challenges and technology developments" report has been added to ResearchAndMarkets.com's offering.
Pharmaceuticals: Drifting towards Big Data & Analytics is an attempt to analyze the key trends expected to impact the Pharmaceuticals industry and its various stakeholders in 2018.
Although the adoption of big data in pharmaceutical operations has been focused mostly on R&D, vendors are exploring its potential use in other operational processes. In supply chain, it helps pharmaceutical companies diagnose issues in their logistics, supplier performance, procurement, delays in delivery, demand management, etc. Vendors are launching BDA solutions that focus on increasing supply chain productivity of pharmaceutical companies.
With competition increasing in the pharmaceutical sector and the market flooded with a multitude of treatments and therapies, determining drug efficacy and designing market strategies remains a priority, while maintaining drug safety. The use of big data in these operational domains will enable pharmaceutical companies to introduce innovations in both products and processes. With digital transformation being the main priority of most pharmaceutical enterprises, the adoption of BDA and AI platforms are expected to increase in the coming years.
Reasons to Buy
2 Challenges Impacting Pharmaceuticals in Big Data Analytics
3 Market Dynamics
4 BI Investment Priorities in the Pharmaceutical Sector
5 Market Size and Forecast
7 Future Outlook
For more information about this report visit https://www.researchandmarkets.com/research/bc5jqg/worldwide?w=4
Source: Research and Markets